The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The condition can be treated with a broad range of drugs and implants available in the market.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Definition

Vendor segmentation

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by product

Global ED treatment market by product

Global ED drugs market

Global ED devices market

PART 07: Market segmentation by type of ED drugs

Global ED treatment market by type of ED drugs

PART 08: Market segmentation by type of ED device

Global ED treatment market by type of ED device

PART 09: Geographical segmentation

Global ED treatment market by geography

ED treatment market in Americas

ED treatment market in EMEA

ED treatment market in APAC

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

Competitive scenario

PART 16: Key vendor analysis

Bayer

Boston Scientific

Coloplast

Eli Lilly

Pfizer

Other prominent vendors

PART 17: Appendix

List of abbreviations

PART 18: Explore Technavio